LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $657,000 | +214.4% | 5,752 | +245.7% | 0.00% | +300.0% |
| Q1 2019 | $209,000 | -39.4% | 1,664 | -34.5% | 0.00% | -50.0% |
| Q4 2018 | $345,000 | -49.0% | 2,539 | +2.9% | 0.00% | -50.0% |
| Q3 2018 | $677,000 | +25.6% | 2,468 | -5.1% | 0.00% | +33.3% |
| Q2 2018 | $539,000 | +25.3% | 2,600 | -0.2% | 0.00% | 0.0% |
| Q1 2018 | $430,000 | +23.6% | 2,605 | +2.4% | 0.00% | +50.0% |
| Q4 2017 | $348,000 | +5.8% | 2,544 | +5.3% | 0.00% | 0.0% |
| Q3 2017 | $329,000 | +47.5% | 2,416 | +31.3% | 0.00% | +100.0% |
| Q2 2017 | $223,000 | -7.1% | 1,840 | -18.8% | 0.00% | 0.0% |
| Q1 2017 | $240,000 | – | 2,267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |